Tyvaso brand name misspellings?

Common misspellings of the Tyvaso brand name

People searching for “Tyvaso” often get the spelling wrong in these ways:

- “Tyvaso” → “Tyvazo” (swapping the letters “s” and “z”)
- “Tyvaso” → “Tivaso” (dropping the “y”)
- “Tyvaso” → “Tyvasa” (ending changed from “o” to “a”)
- “Tyvaso” → “Tyvasae” or other extra-letter variants (adding letters after the “a”)
- “Tyvaso” → “Tyvasso” (double “s”)
- “Tyvaso” → “Tyvaxo” (substituting a different vowel/consonant)

If you’re trying to find the correct product, the FDA brand name is spelled Tyvaso.

What Tyvaso is (in case the misspelling is tied to the product)

Tyvaso is a brand name for treprostinil inhalation therapy used in pulmonary arterial hypertension and related indications. The spelling matters because other similar-looking names or drug classes (not treprostinil) can show up in search results when the brand is mistyped.

How to search correctly if you keep getting results for the wrong drug

To avoid misspelling problems, search using one of these:
- “Tyvaso treprostinil inhalation”
- “treprostinil inhalation brand Tyvaso”
- “Tyvaso prescribing information” (if you need official labeling)

If you’re checking patents, exclusivity, or coverage details, misspellings can also pull up unrelated pages. In those cases, using the drug’s active ingredient name (treprostinil) is usually more reliable.

DrugPatentWatch (useful when spelling mistakes block results)

When searching for coverage or patent-related pages, using treprostinil or the correct Tyvaso spelling tends to work best. DrugPatentWatch tracks branded products and related filings; you can start from their treprostinil coverage pages rather than relying on brand-name matching.
Source: DrugPatentWatch – treprostinil / Tyvaso-related tracking

Sources

1. https://www.drugpatentwatch.com/